Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $335 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare (NYSE:HCA), with a maintained price target of $335.

April 10, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on HCA Healthcare, with a price target of $335.
The reiteration of an Overweight rating by a reputable analyst, along with a high price target, suggests a positive outlook for HCA Healthcare's stock. This endorsement could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100